RxDoctor Payments Data

Ashley Ruffing

Gerontology · Naples, FLNPI 1730629718

Payments from drug & device makers

$3,034in general payments, 2019–2025

Across 146 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$902
  • AstraZeneca$629
  • Regeneron Healthcare Solutions, Inc.$331
  • Sanofi$163
  • Philips North America LLC$162
  • Paratek Pharmaceuticals, Inc.$162
  • plus $686 from 15 others

What the payments were for

  • Food & beverage$3,034100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,034 in reported general payments places this provider in the 85th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$42,157
Medicare patients
212
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter168$163,215
Dupixent PenDupilumab11$40,731
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr56$33,291
Breo ElliptaFluticasone/Vilanterol49$22,953
EliquisApixaban19$13,764
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,686
SymbicortBudesonide/Formoterol Fumarate15$5,717
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$3,480
Albuterol Sulfate HfaAlbuterol Sulfate111$3,327
Ventolin HfaAlbuterol Sulfate56$2,949
Advair DiskusFluticasone Propion/Salmeterol11$2,524
Fluticasone Propionate77$1,397
Azelastine Hcl50$1,216
Montelukast Sodium91$944
Pantoprazole Sodium37$530

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$902$219,459273 claims
AstraZenecaBreztri Aerosphere, Symbicort$629$17,40333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 714 gerontology providers in Florida.

Other gerontology in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →